Additionally, EMAST has recently been linked to high levels of CD8+ tumor-infiltrating lymphocytes and PD-L1 expression in tumor and immune cells of CRC, suggesting increased immunogenicity and a potential value as a predictive biomarker for ICI [17]. Here, CD8A is linked to neoplasm.